CSBR:NASDAQ
Champions Oncology Inc
US$4,59
arrow_downward
-1,89%(-0,088) 1D
17 ພ.ຈ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$4,70
High
US$4,70
Low
US$4,59
Mkt. cap
63,91 ລ້ານ
Avg. vol.
7,80 ພັນ
Volume
4,63 ພັນ
52-wk high
US$8,31
52-wk low
US$4,52
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
Open
US$4,70
High
US$4,70
Low
US$4,59
Mkt. cap
63,91 ລ້ານ
Avg. vol.
7,80 ພັນ
Volume
4,63 ພັນ
52-wk high
US$8,31
52-wk low
US$4,52
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
News stories
From web sources and news partners
ChartMill
·
1 ຊົ່ວໂມງກ່ອນ
S&P 500 Losers: Software Stocks Lead Session Declines
Fox Business
·
1 ຊົ່ວໂມງກ່ອນ
S&P 500 decline driven by semiconductor confidence issues, says Scott Chronert
MarketWatch
·
50 ນາທີກ່ອນ
Only two ‘Magnificent Seven’ stocks have managed to beat the S&P 500 since the start of 2025
Traders Union
·
1 ຊົ່ວໂມງກ່ອນ
Bitcoin-to-S&P 500 ratio holds trendline support, James Van Straten notes
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ນິວເຈີຊີ, ສະຫະລັດ
SectorHealth Care
Industry-
Websitechampionsoncology.com